← All Novo Integrated Sciences, INC filings

Novo Integrated Sciences, INC 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

OTC.Pink
NVOS
Novo Integrated Sciences, INC
10-Q: Novo Integrated Sciences Reports Q3 2024 Results Amidst Financial Restructuring
Novo Integrated Sciences reported its Q3 2024 financial results, showing a net loss and ongoing efforts to manage debt and improve operations.
OTC.Pink
NVOS
Novo Integrated Sciences, INC
10-Q: Novo Integrated Sciences Reports Q2 2024 Results, Revenue Up 24% Year-Over-Year
Novo Integrated Sciences, Inc. reports a 24% increase in revenue for the second quarter of 2024 compared to the same period last year, driven primarily by product sales.
OTC.Pink
NVOS
Novo Integrated Sciences, INC
10-Q: Novo Integrated Sciences Reports Increased Revenue but Widened Net Loss in Q1 2024
Novo Integrated Sciences saw a revenue increase in the first quarter of 2024, but also experienced a larger net loss compared to the same period last year.